ArticleProceedings of the National Academy of Sciences of the United States of America2012

Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.

Kristen A Rahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.